𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Symptomatic Treatment of Huntington Disease

✍ Scribed by Octavian R. Adam; Joseph Jankovic


Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
230 KB
Volume
5
Category
Article
ISSN
1933-7213

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A pilot study using nabilone for symptom
✍ Adrienne Curtis; Ian Mitchell; Smitaa Patel; Natalie Ives; Hugh Rickards πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 1 views

## Abstract Pilot study of nabilone in Huntington's disease (HD). Double‐blind, placebo‐controlled, cross‐over study of nabilone versus placebo. Primary outcome, Unified Huntington's Disease Rating Scale (UHDRS) total motor score. Secondary measures: UHDRS subsections for chorea, cognition and beha

Spectrum of gait impairments in presympt
✍ Ashwini K. Rao; Lisa Muratori; Elan D. Louis; Carol B. Moskowitz; Karen S. Marde πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 155 KB

## Abstract The purpose of this study was to quantify gait impairments in presymptomatic and symptomatic Huntington's disease (HD) subjects, and examine sensitivity of gait measures. Our sample (n = 65) included presymptomatic mutation carriers (PMC) (n = 15), symptomatic HD subjects (SHD) (n = 30)

Rate of caudate atrophy in presymptomati
✍ Elizabeth H. Aylward; Ann Marie Codori; Adam Rosenblatt; Meeia Sherr; Jason Bran πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 150 KB πŸ‘ 2 views

Previous research by our group demonstrated a longitudinal change in caudate volume for symptomatic subjects with Huntington's disease (HD), and suggested that volume of the caudate may be a useful outcome measure for therapeutic studies in symptomatic patients. The current study was designed to det